Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2017

Open Access 01-12-2017 | Research article

Prevalence, patterns, and perceived value of complementary and alternative medicine among HIV patients: a descriptive study

Author: Mandreker Bahall

Published in: BMC Complementary Medicine and Therapies | Issue 1/2017

Login to get access

Abstract

Background

Use of complementary and alternative medicine (CAM) is widespread among different patient populations despite the availability of evidence-based conventional medicine and lack of supporting evidence for the claims of most CAM types. This study explored the prevalence, patterns, and perceived value of CAM among human immunodeficiency virus (HIV) patients.

Methods

This quantitative descriptive study was conducted between November 1, 2014 and March 31, 2015 among a cross-sectional, convenience sample of attendees of the HIV clinic of a public tertiary health care institution. Face-to-face interviews using a 34-item questionnaire were conducted. Data analysis included descriptive statistics, chi-square tests, and binary logistic regression analysis.

Results

CAM was used by 113 (32.8%) of a total of 343 HIV patients, but <1% informed their health care providers of CAM usage. Medicinal herbs were the most common type of CAM used (n = 110, 97.3%) followed by spiritual therapy (n = 56, 49.6%), including faith healing/prayer and meditation. The most used medicinal herbs were Aloe vera (n = 54, 49.1%), ginger (n = 33, 30.0%), and garlic (n = 23, 20.9%). The most used vitamins were complex B vitamins (n = 70, 61.9%), followed by vitamin A (n = 58, 51.3%), vitamin E (n = 51, 45.1%), and vitamin D (n = 42, 37.1%). Most CAM users continued using conventional medicine in addition to CAM and were willing to use CAM without supervision and without informing their health care provider. Patients were generally satisfied with CAM therapy (n = 91, 80.5%). The main reasons for CAM use were the desire to take control of their treatment (8.8%) or just trying anything that could help (18.8%). Main influences were the mass media (32.7%) and non-hospital health personnel (19.5%). Predictors of CAM use were being 30–50 years, married and having a secondary school education.

Conclusion

About one-third of HIV patients used CAM, but virtually none informed their healthcare provider. Medicinal herbs were the most common type of CAM, followed by spiritual therapy and vitamins. A patient’s decision to use CAM was influenced for the most part by the mass media and non- hospital health care personnel.
Literature
1.
Chen RY, Accortt NA, Westfall AO, Mugavero MJ, Raper JL, Cloud GA, et al. Distribution of health care expenditures for HIV-infected patients. Clin Infect Dis. 2006;42:1003–10.CrossRefPubMed
2.
Mugavero MJ, Norton WE, Saag MS. Health care system and policy factors influencing engagement in HIV medical care: piecing together the fragments of a fractured health care delivery system. Clin Infect Dis. 2011;52:S238–46.CrossRefPubMedPubMedCentral
3.
Fairfield KM, Eisenberg DM, Davis RB, Libman H, Phillips RS. Patterns of use, expenditures, and perceived efficacy of complementary and alternative therapies in HIV-infected patients. Arch Intern Med. 1998;158:2257–64.CrossRefPubMed
4.
Foote-Ardah CE. The meaning of complementary and alternative medicine practices among people with HIV in the United States: strategies for managing everyday life. Sociol Health Illn. 2003;25:481–500.CrossRefPubMed
5.
Chinouya M, Davidson O. The Padare Project: assessing health-related knowledge, attitudes and behaviours of HIV-positive Africans accessing services in north central London. London: African HIV Policy Network; 2003.
6.
Peltzer K, Preez NF, Ramlagan S, Fomundam H. Use of traditional complementary and alternative medicine for HIV patients in KwaZulu-Natal. South Africa BMC Public Health. 2008;8:255.CrossRefPubMed
7.
Chen WT, Shiu CS, Simoni J, Fredriksen-Goldsen K, Zhang F, Starks H, et al. Attitudes toward antiretroviral therapy and complementary and alternative medicine in Chinese HIV-infected patients. J Assoc Nurses AIDS Care. 2009;20:203–17.CrossRefPubMedPubMedCentral
8.
Littlewood RA, Vanable PA. Complementary and alternative medicine use among HIV+ people: research synthesis and implications for HIV care. AIDS Care. 2008;20:1002–18.CrossRefPubMedPubMedCentral
9.
Tabish SA. Complementary and alternative healthcare: is it evidence-based? Int J Health Sci (Qassim). 2008;2:V–IX.
10.
Zou W, Liu Y, Wang J, Li H, Liao X. Traditional Chinese herbal medicines for treating HIV infections and AIDS. Evid Based Complement Alternat Med. 2012;2012:950757.CrossRefPubMedPubMedCentral
11.
12.
Harris PE, Cooper KL, Relton C, Thomas KJ. Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update. Int J ClinPract. 2012;66:924–39.
13.
14.
Posadzki P, Watson LK, Alotaibi A, Ernst E. Prevalence of use of complementary and alternative medicine (CAM) by patients/consumers in the UK: systematic review of surveys. Clin Med. 2013;13:126–31.CrossRef
15.
Xue CC, Zhang AL, Lin V, Da Costa C, Story DF. Complementary and alternative medicine use in Australia: a national population-based survey. J Altern Complement Med. 2007;13:643–50.CrossRefPubMed
16.
Clement YN, Williams AF, Aranda D, Chase R, Watson N, Mohammed R, et al. Medicinal herb use among asthmatic patients attending a specialty care facility in Trinidad. BMC Complement Altern Med. 2005;5:3.CrossRefPubMedPubMedCentral
17.
18.
Mahabir D, Gulliford MC. Use of medicinal plants for diabetes in Trinidad and Tobago. Rev Panam Salud Publica. 1997;1:174–9.CrossRefPubMed
19.
Duggan J, Peterson WS, Schutz M, Khuder S, Charkraborty J. Use of complementary and alternative therapies in HIV-infected patients. AIDS Patient Care STDs. 2001;15:159–67.CrossRefPubMed
20.
Hsiao AF, Wong MD, Kanouse DE, Collins RL, Liu H, Andersen RM, et al. Complementary and alternative medicine use and substitution for conventional therapy by HIV-infected patients. J Acquir Immune Defic Syndr. 2003;33:157–65.CrossRefPubMed
21.
Payne-Jackson A, Alleyne MC. Jamaican folk medicine: a source of healing. Barbados: The University of the West Indies Press; 2004.
22.
Clement Y. Limited clinical evidence to support the integration of Caribbean herbs into conventional medicine. Focus Altern Complement Ther. 2011;16:289–92.CrossRef
23.
Frass M, Strassl RP, Friehs H, Müllner M, Kundi M, Kaye AD. Use and acceptance of complementary and alternative medicine among the general population and medical personnel: a systematic review. Ochsner J. 2012;12:45–56.PubMedPubMedCentral
24.
Moyne L, Stubbs R, Crowdy RE, Citrine W, Mackinnon P, Blacklock MG, et al. West India Royal Commission Report. London: Her Majesty’s Stationery Office; 1945. (Command 6607)
25.
Hsu C, Bluespruce J, Sherman K, Cherkin D. Unanticipated benefits of CAM therapies for back pain: an exploration of patient experiences. J Altern Complement Med. 2010;16:157–63.CrossRefPubMedPubMedCentral
26.
Laptiste C, Beharry V, Edwards-Wescott P. A review of the response to HIV/AIDS in Trinidad and Tobago: 1983–2010. Sahara J. 2013;10:72–82.CrossRefPubMed
27.
28.
Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry. 2001;158:725–30.CrossRefPubMed
29.
Owe-Larsson B, Säll L, Salamon E, Allgulander C. HIV infection and psychiatric illness. Afr J Psychiatry (Johannesbg). 2009;12:115–28.
30.
Kalichman SC, Heckman T, Kochman A, Sikkema K, Bergholte J. Depression and thoughts of suicide among middle-aged and older persons living with HIV-AIDS. Psychiatr Serv. 2000;51:903–7.CrossRefPubMed
31.
Ballester-Arnal R, Gómez-Martínez S, Fumaz CR, González-García M, Remor E, Fuster MJ. A Spanish study on psychological predictors of quality of life in people with HIV. AIDS Behav. 2016;20:281–91.CrossRefPubMed
32.
Turan JM, Bukusi EA, Onono M, Holzemer WL, Miller W, Cohen CR. HIV/AIDS stigma and refusal of HIV testing among pregnant women in rural Kenya: results from the MAMAS study. AIDS Behav. 2011;15:1111–20.CrossRefPubMed
33.
Dlamini PS, Kohi TW, Uys LR, Phetlhu RD, Chirwa ML, Naidoo JR, et al. Verbal and physical abuse and neglect as manifestations of HIV/AIDS stigma in five African countries. Public Health Nurs. 2007;24:389–99.CrossRefPubMed
34.
35.
36.
37.
Rivera-Rodriguez AJ, Karsh B-T. Interruptions and distractions in healthcare review and reappraisal. Qual Saf Health Care. 2010;19:304–12.CrossRefPubMed
38.
Institute of Medicine. Crossing the Quality Chasm: a New Health System for the 21st Century. Washington, D.C.: National Academies Press; 2001.
39.
40.
May MT, Gompels M, Delpech V, Porter K, Orkin C, Kegg S, et al. Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy. AIDS. 2014;28:1193–202.CrossRefPubMedPubMedCentral
41.
42.
43.
Namuddu B, Kalyango JN, Karamagi C, Mudiope P, Sumba S, Kalende H, et al. Prevalence and factors associated with traditional herbal medicine use among patients on highly active antiretroviral therapy in Uganda. BMC Public Health. 2011;11:855.CrossRefPubMedPubMedCentral
44.
Wiwanitkit V. The use of CAM by HIV-positive patients in Thailand. Complement Ther Med. 2003;11:39–41.CrossRefPubMed
45.
Falci L, Shi Z, Greenlee H. Multiple chronic conditions and use of complementary and alternative medicine among US adults: Results from the 2012 National Health Interview Survey. Prev Chronic Dis. 2016;13:150501.CrossRef
46.
Oyunchimeg B, Hwang JH, Ahmed M, Choi S, Han D. Complementary and alternative medicine use among patients with cancer in Mongolia: a National hospital survey. BMC Complement Altern Med. 2017;17:58.CrossRefPubMedPubMedCentral
47.
Lorenc A, Robinson N. A review of the use of complementary and alternative medicine and HIV: Issues for patient care. AIDS Patient Care STDs. 2013;27:503–10.CrossRefPubMedPubMedCentral
48.
Idung AU, Abasiubong F. Complementary and alternative medicine use among HIV-infected patient’s on anti-retroviral therapy in the Niger Delta Region. Nigeria Clin Med Res. 2014;3:153–8.CrossRef
49.
Owen-Smith A, McCarty F, Hankerson-Dyson D, DiClemente R. Prevalence and predictors of complementary and alternative medicine use in African-Amerians with acquired immune deficiency syndrome. Focus Altern Complement Ther. 2012;17:33–42.CrossRefPubMedPubMedCentral
50.
Abou-Rizk J, Alameddine M, Naja F. Prevalence and characteristics of CAM use among people living with HIV and AIDS in Lebanon: Implications for patient care. Evid Based Complement Alternat Med. 2016;2016:5013132.CrossRefPubMedPubMedCentral
51.
Josephs JS, Fleishman JA, Gaist P, Gebo KA. HIV Research Network. Use of complementary and alternative medicines among a multistate, multisite cohort of people living with HIV/AIDS. HIV Med. 2007;8:300–5.CrossRefPubMed
52.
Naccarato M, Yoong D, Gough K. A potential drug–herbal interaction between Ginkgo biloba and efavirenz. J Int Assoc Physicians AIDS Care (Chic). 2012;11:98–100.CrossRef
53.
54.
Cotton S, Puchalski CM, Sherman SN, Mrus JM, Peterman AH, Feinberg J, et al. Spirituality and religion in patients with HIV/AIDS. J Gen Intern Med. 2006;21:S5–13.CrossRefPubMedPubMedCentral
55.
Montessori V, Press N, Harris M, Akagi L, Montaner J. Adverse effects of antiretroviral therapy for HIV infection. CMAJ. 2004;170:229–38.PubMedPubMedCentral
56.
Nichol J, Thompson EA, Shaw A. Beliefs, decision-making, and dialogue about complementary and alternative medicine (CAM) within families using CAM: a qualitative study. J Altern Complement Med. 2011;17:117–25.CrossRefPubMed
57.
Orisatoki RO, Oguntibeju OO. The role of herbal medicine use in HIV/AIDS treatment. AC Microb. 2010;1:3.
58.
Langlois-Klassen D, Kipp W, Jhangri GS, Rubaale T. Use of traditional herbal medicine by AIDS patients in Kabarole District, Western Uganda. Am J Trop Med Hyg. 2007;77:757–63.PubMed
59.
Limsatchapanich S, Sillabutra J, Nicharojana LO. Factors related to the use of complementary and alternative medicine among people living with HIV/AIDS in Bangkok. Thailand Health Sci J. 2013;7:436–46.
60.
Hussain S, Malik F. Integration of complementary and traditional medicines in public health care systems: challenges and methodology. J Med Plant Res. 2013;7:2952–9.
61.
62.
Wahner-Roedler DL, Vincent A, Elkin PL, Loehrer LL, Cha SS, Bauer BA. Physicians’ attitudes toward complementary and alternative medicine and their knowledge of specific therapies: A survey at an academic medical center. Evid Based Complement Alternat Med. 2006;3:495–501.CrossRefPubMedPubMedCentral
63.
Bahall M, Legall G. Knowledge, attitudes, and practices among health care providers regarding complementary and alternative medicine in Trinidad and Tobago. BMC Complement Altern Med. 2017;17:144.CrossRefPubMedPubMedCentral
64.
65.
Liu C, Yang Y, Gange SJ, Weber K, Sharp GB, Wilson TE, et al. Disclosure of complementary and alternative medicine use to health care providers among HIV-infected women. AIDS Patient Care STDs. 2009;23:965–71.CrossRefPubMedPubMedCentral
66.
Robinson A, McGrail MR. Disclosure of CAM use to medical practitioners: a review of qualitative and quantitative studies. Complement Ther Med. 2004;12:90–8.CrossRefPubMed
67.
68.
Tachjian A, Maria V, Jahangir A. Use of herbal products and potential interactions in patients with cardiovascular diseases. J Am Coll Cardiol. 2010;55:515–25.CrossRefPubMedPubMedCentral
69.
Lee LS, Andrade AS, Flexner C. Interactions between natural health products and antiretroviral drugs: pharmacokinetic and pharmacodynamic effects. Clin Infect Dis. 2006;43:1052–9.CrossRefPubMed
70.
71.
Metadata
Title
Prevalence, patterns, and perceived value of complementary and alternative medicine among HIV patients: a descriptive study
Author
Mandreker Bahall
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2017
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-017-1928-4

Other articles of this Issue 1/2017

BMC Complementary Medicine and Therapies 1/2017 Go to the issue

Research article

Prevalence, patterns, and perceived value of complementary and alternative medicine among cancer patients: a cross-sectional, descriptive study

Research article

Coronary angiogenic effect of long-term administration of Nigella sativa

Research article

Vasorelaxant effects of Angelica decursiva root on isolated rat aortic rings

Research article

Ameliorative potential of Alstonia scholaris (Linn.) R. Br. against chronic constriction injury-induced neuropathic pain in rats

Research article

Complementary and conventional providers in cancer care: experience of communication with patients and steps to improve communication with other providers

Research article

Effects of stevia on synaptic plasticity and NADPH oxidase level of CNS in conditions of metabolic disorders caused by fructose